nach oben

Erschienen in:

2025 | OriginalPaper | Buchkapitel

19. Prädiktiver Ultraschall, Screening und Vorhersage für Präeklampsie und fetale Wachstumsrestriktion im II. und III. Trimester

verfasst von : Prof. Dr. med. Stefan Verlohren, Priv.-Doz. Dr. med. Arne Willruth, Prof. Dr. med. Ulrich Gembruch

Erschienen in: Ultraschalldiagnostik in Geburtshilfe und Gynäkologie

Verlag: Springer Berlin Heidelberg

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die Dopplersonografie der Aa. uterinae im II. Trimester kann, mit besseren Detektionsraten als im I. Trimester grundsätzlich Fälle mit Präeklampsie und fetaler Wachstumsrestriktion (fetal growth restriction, FGR; auch intrauterine growth restriction, IUGR, genannt) vorhersagen, ist jedoch aufgrund ihrer geringen Sensitivität nicht als alleinige Screeningmethode geeignet. Eine multiparametrsiche Risikostratifizierung basierend auf maternalen Risikofaktoren und Charakteristika, zusätzlichen biochemischen Serummarkern und Dopplersonographie hat das Potenzial, Schwangere mit einem erhöhten Risiko und behandelbaren Risikofaktoren für Präeklampsie und auch FGR zu identifizieren, um sie frühzeitig einer personalisierten Therapie und intensiveren Überwachung der Schwangerschaft zuzuführen. Auch im III. Trimester kann durch dieses Vorgehen eine weitere Risikostratifizierung bezüglich später Präeklampsie, FGR und adversem neonatalen Outcome erfolgen und das perinatale Management entsprechend modifiziert werden.

Vorheriges Kapitel Schwierigkeiten der pränatalen Diagnostik und fetalen Überwachung bei maternaler Adipositas

Nächstes Kapitel Geburtshilfliche Zervixsonographie und Diagnostik der drohenden Frühgeburt

ACOG (2013) Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’Task Force on Hypertension in Pregnancy. Obstet Gynecol 22:1122–1131

ACOG (2020) Gestational hypertension and preeclampsia: ACOG Practice Bulletin, number 22. Obstet Gynecol 135:e237–e260CrossRef

Akolekar R, Panaitescu AM, Ciobanu A, Syngelaki A, Nicolaides KH (2019) Two-stage approach for prediction of small-for-gestational-age neonate and adverse perinatal outcome by routine ultrasound examinationn at 35–37 weeks’ gestation. Ultrasound Obstet Gynecol 54:484–491PubMedCrossRef

Akolekar R, Syngelaki A, Sarquis R, Zvanca M, Nicolaides KH (2011) Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11–13 weeks. Prenat Diagn 31:66–74PubMedCrossRef

Albaiges G, Missfelder-Lobos H, Lees C, Parra M, Nicolaides KH (2000) One-stage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23 weeks’ gestation. Obstet Gynecol 96:559–564PubMed

Arakaki T, Hasegawa J, Nakamura M, Hamada S, Muramoto M, Takita H, Ichizuka K, Sekizawa A (2015) Prediction of early- and late-onset pregnancy-induced hypertension using placental volume on three-dimensional ultrasound and uterine artery Doppler. Ultrasound Obstet Gynecol 45:539–543PubMedCrossRef

Ashoor G, Syngelaki A, Papastefanou I, Nicolaides KH, Akolekar R (2022) Development and validation of model for prediction of placental dysfunction-related stillbirth from maternal factors, fetal weight and uterine artery Doppler at mid-gestation. Ultrasound Obstet Gynecol 59:61–68PubMedCrossRef

Askie LM, Duley L, Henderson-Smart DJ, Stewart LA (2007) Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 369:1791–1798PubMedCrossRef

AWMF (2019) Hypertensive pregnancy disorders: Diagnosis and therapy. Guideline of the German Society of Gynecology and Obstetrics (S2k-Level), AWMF-Registry No. 015/018. https://www.awmf.org/leitlinien/detail/ll/015-018html

Bakalis S, Silva M, Akolekar R, Poon LC, Nicolaides KH (2015a) Prediction of small-for-gestational-age neonates: screening by fetal biometry at 30–34 weeks. Ultrasound Obstet Gynecol 45:551–558PubMedCrossRef

Bakalis S, Stoilov B, Akolekar R, Poon LC, Nicolaides KH (2015b) Prediction of small-for-gestational-age neonates: screening by uterine artery Doppler and mean arterial pressure at 30–34 weeks. Ultrasound Obstet Gynecol 45:707–714PubMedCrossRef

Bamfo JE, Kametas NA, Chambers JB, Nicolaides KH (2008) Maternal cardiac function in normotensive and pre-eclamptic intrauterine growth restriction. Ultrasound Obstet Gynecol 32:682–686PubMedCrossRef

Barker DJ, Eriksson JG, Forsen T, Osmond C (2002) Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol 31:1235–1239PubMedCrossRef

Baschat AA (2015) First-trimester screening for pre-eclampsia: moving from personalized risk prediction to prevention. Ultrasound Obstet Gynecol 45:119–129PubMedCrossRef

Bellamy L, Casas JP, Hingorani AD, Williams DJ (2007) Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 335:974PubMedPubMedCentralCrossRef

Breeze AC, Lees CC (2007) Prediction and perinatal outcomes of fetal growth restriction. Semin Fetal Neonatal Med 12:383–397PubMedCrossRef

Brosens I, Pijnenborg R, Vercruysse L, Romero R (2011) The “Great Obstetrical Syndromes” are associated with disorders of deep placentation. Am J Obstet Gynecol 204:193–201PubMedCrossRef

Brouwers L, van der Meiden-van Roest AJ, Savelkoul C, Vogelvang TE, Lely AT, Franx A, van Rijn BB (2018) Recurrence of pre-eclampsia and the risk of future hypertension and cardiovascular disease: a systematic review and meta-analysis. BJOG 125:1642–1654PubMedPubMedCentralCrossRef

Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, Hall DR, Warren CE, Adoyi G, Ishaku S, International Society for the Study of Hypertension in Pregnancy (ISSHP) (2018) The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens 13:291–310PubMedCrossRef

Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, Forest JC, Giguere Y (2010) Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 116:402–414PubMedCrossRef

Burton GJ, Yung HW, Cindrova-Davies T, Charnock-Jones DS (2009) Placental endoplasmic reticulum stress and oxidative stress in the pathophysiology of unexplained intrauterine growth restriction and early onset preeclampsia. Placenta 30(Suppl A):S43–S48PubMedCrossRef

Ciobanu A, Formuso C, Syngelaki A, Akolekar R, Nicolaides KH (2019a) Prediction of small-for-gestational-age neonates at 35-37 weeks’ gestation: contribution of maternal factors and growth velocity between 20 and 36 weeks. Ultrasound Obstet Gynecol 53:488–495PubMedCrossRef

Ciobanu A, Khan N, Syngelaki A, Akolekar R, Nicolaides KH (2019b) Routine ultrasound at 32 vs 36 weeks’ gestation: prediction of small-for-gestational-age neonates. Ultrasound Obstet Gynecol 53:761–768PubMedCrossRef

Ciobanu A, Rouvali A, Syngelaki A, Akolekar R, Nicolaides KH (2019c) Prediction of small for gestational age neonates: screening by maternal factors, fetal biometry, and biomarkers at 35–37 weeks’ gestation. Am J Obstet Gynecol 220:486.e1–486.11PubMedCrossRef

Ciobanu A, Wright A, Panaitescu A, Syngelaki A, Wright D, Nicolaides KH (2019d) Prediction of imminent preeclampsia at 35–37 weeks gestation. Am J Obstet Gynecol 220:584.e1–584.e11PubMedCrossRef

Cnossen JS, Morris RK, ter Riet G, Mol BW, van der Post JA, Coomarasamy A, Zwinderman AH, Robson SC, Bindels PJ, Kleijnen J, Khan KS (2008) Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable metaanalysis. CMAJ 178:701–711PubMedPubMedCentralCrossRef

Cruz-Martinez R, Savchev S, Cruz-Lemini M, Mendez A, Gratacos E, Figueras F (2015) Clinical utility of third-trimester uterine artery Doppler in the prediction of brain hemodynamic deterioration and adverse perinatal outcome in small-for-gestational-age fetuses. Ultrasound Obstet Gynecol 45:273–278PubMedCrossRef

De La Calle M, Delgado JL, Verlohren S, Escudero AI, Bartha JL, Campillos JM, Aguarón De La Cruz A, Chantraine F, García Hernández JÁ, Herraiz I, Llurba E, Kurka H, Guo G, Sillman J, Hund M, Perales Marín A (2021) Gestational age-specific reference ranges for the sFlt-1/PlGF immunoassay ratio in twin pregnancies. Fetal Diagn Ther 48:288–296PubMedCrossRef

Diab AE, El-Behery MM, Ebrahiem MA, Shehata AE (2008) Angiogenic factors for the prediction of pre-eclampsia in women with abnormal midtrimester uterine artery Doppler velocimetry. Int J Gynaecol Obstet 102:146–151PubMedCrossRef

Dragan I, Wright D, Fiolna M, Leipold G, Nicolaides KH (2017) Development of pre-eclampsia within 4 weeks of sFlt-1/PlGF ratio 〉 38: comparison of performance at 31-34 vs 35–37 weeks’ gestation. Ultrasound Obstet Gynecol 49:209–212PubMedCrossRef

Dröge LA, Perschel FH, Stütz N, Gafron A, Frank L, Busjahn A, Henrich W, Verlohren S (2021) Prediction of preeclampsia-related adverse outcomes with the sFlt-1 (soluble fms-like tyrosine kinase 1)/PlGF (placental growth factor)-ratio in the clinical routine: a real-world study. Hypertension 77:461–471PubMedCrossRef

Dubon Garcia A, Devlieger R, Redekop K, Vandeweyer K, Verlohren S, Poon LC (2021) Cost-utility of a first-trimester screening strategy versus the standard of care for nulliparous women to prevent pre-term pre-eclampsia in Belgium. Pregnancy Hypertens 25:219–224PubMedCrossRef

Duckitt K, Harrington D (2005) Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 330:565PubMedPubMedCentralCrossRef

Duley L, Henderson-Smart DJ, Meher S, King JF (2007) Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev https://doi.org/10.1002/14651858.CD004659 CrossRefPubMedPubMedCentral

Egbor M, Ansari T, Morris N, Green CJ, Sibbons PD (2006) Morphometric placental villous and vascular abnormalities in early- and late-onset preeclampsia with and without fetal growth restriction. BJOG 113:580–589PubMedCrossRef

Espinoza J, Romero R, Nien JK, Gomez R, Kusanovic JP, Goncalves LF, Medina L, Edwin S, Hassan S, Carstens M, Gonzalez R (2007) Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor. Am J Obstet Gynecol 196:326.e1–326.e13PubMedCrossRef

Figueras F, Gardosi J (2011) Intrauterine growth restriction: new concepts in antenatal surveillance, diagnosis, and management. Am J Obstet Gynecol 204:288–300PubMedCrossRef

Florio P, Reis FM, Pezzani I, Luisi S, Severi FM, Petraglia F (2003) The addition of activin A and inhibin A measurement to uterine artery Doppler velocimetry to improve the early prediction of pre-eclampsia. Ultrasound Obstet Gynecol 21:165–169PubMedCrossRef

Francisco C, Wright D, Benkő Z, Syngelaki A, Nicolaides KH (2017a) Hidden high rate of pre-eclampsia in twin compared with singleton pregnancy. Ultrasound Obstet Gynecol 50:88–92PubMedCrossRef

Francisco C, Wright D, Benkő Z, Syngelaki A, Nicolaides KH (2017b) Competing-risks model in screening for pre-eclampsia in twin pregnancy by maternal characteristics and medical history. Ultrasound Obstet Gynecol 50:501–506PubMedCrossRef

Frusca T, Soregaroli M, Valcamonico A, Guandalini F, Danti L (1997) Doppler velocimetry of the uterine arteries in nulliparous women. Early Hum Dev 48:177–185PubMedCrossRef

Gabbay-Benziv R, Oliveira N, Baschat AA (2016) Optimal first trimester preeclampsia prediction: a comparison of multimarker algorithm, risk profiles and their sequential application. Prenat Diagn 36:34–39PubMedCrossRef

Gallo DM, Wright D, Casanova C, Campanero M, Nicolaides KH (2016) Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19–24 weeks’ gestation. Am J Obstet Gynecol 214:619.e1–619.17PubMedCrossRef

Gardosi J, Figueras F, Clausson B, Francis A (2011) The customised growth potential: an international research tool to study the epidemiology of fetal growth. Paediatr Perinat Epidemiol 25:2–10PubMedCrossRef

Gebb J, Dar P (2011) Colour Doppler ultrasound of spiral artery blood flow in the prediction of pre-eclampsia and intrauterine growth restriction. Best Pract Res Clin Obstet Gynaecol 25:355–366PubMedCrossRef

Geipel A, Berg C, Germer U, Katalinic A, Krapp M, Smrcek J, Gembruch U (2002) Doppler assessment of the uterine circulation in the second trimester in twin pregnancies: prediction of pre-eclampsia, fetal growth restriction and birth weight discordance. Ultrasound Obstet Gynecol 20:541–545PubMedCrossRef

Geipel A, Hennemann F, Fimmers R, Willruth A, Lato K, Gembruch U, Berg C (2011) Reference ranges for Doppler assessment of uterine artery resistance and pulsatility indices in dichorionic twin pregnancies. Ultrasound Obstet Gynecol 37:663–667PubMedCrossRef

Giguere Y, Charland M, Bujold E, Bernard N, Grenier S, Rousseau F, Lafond J, Legare F, Forest JC (2010) Combining biochemical and ultrasonographic markers in predicting preeclampsia: a systematic review. Clin Chem 56:361–375PubMedCrossRef

Gomez O, Figueras F, Fernandez S, Bennasar M, Martinez JM, Puerto B, Gratacos E (2008) Reference ranges for uterine artery mean pulsatility index at 11–41 weeks of gestation. Ultrasound Obstet Gynecol 32:128–132PubMedCrossRef

Gordijn SJ, Beune IM, Thilaganathan B, Papageorghiou A, Baschat AA, Baker PN, Silver RM, Wynia K, Ganzevoort W (2016) Consensus definition of fetal growth restriction: a Delphi procedure. Ultrasound Obstet Gynecol 48:333–339PubMedCrossRef

Grivell R, Dodd J, Robinson J (2009) The prevention and treatment of intrauterine growth restriction. Best Pract Res Clin Obstet Gynaecol 23:795–807PubMedCrossRef

Groom KM, North RA, Poppe KK, Sadler L, McCowan LM (2007) The association between customised small for gestational age infants and pre-eclampsia or gestational hypertension varies with gestation at delivery. BJOG 114:478–484PubMedCrossRef

Hadlock FP, Harrist RB, Sharman RS, Deter RL, Park SK (1985) Estimation of fetal weight with the use of head, body, and femur measurements – a prospective study. Am J Obstet Gynecol 151:333–337PubMedCrossRef

Hafner E, Metzenbauer M, Hofinger D, Stonek F, Schuchter K, Waldhor T, Philipp K (2006) Comparison between three-dimensional placental volume at 12 weeks and uterine artery impedance/notching at 22 weeks in screening for pregnancy-induced hypertension, pre-eclampsia and fetal growth restriction in a low-risk population. Ultrasound Obstet Gynecol 27:652–657PubMedCrossRef

Harrington K, Cooper D, Lees C, Hecher K, Campbell S (1996) Doppler ultrasound of the uterine arteries: the importance of bilateral notching in the prediction of pre-eclampsia, placental abruption or delivery of a small-for-gestational-age baby. Ultrasound Obstet Gynecol 7:182–188PubMedCrossRef

Hodel M, Blank PR, Marty P, Lapaire O (2019) sFlt-1/plGF ratio as a predictive marker in women with suspected preeclampsia: an economic evaluation from a Swiss perspective. Dis Markers 2019:4096847PubMedPubMedCentralCrossRef

Hoftiezer L, Hof MHP, Dijs-Elsinga J, Hogeveen M, Hukkelhoven CWPM, van Lingen RA (2019) From population reference to national standard: new and improved birthweight charts. Am J Obstet Gynecol 220:383.e1–383.e17PubMedCrossRef

Hollis B, Prefumo F, Bhide A, Rao S, Thilaganathan B (2003) First-trimester uterine artery blood flow and birth weight. Ultrasound Obstet Gynecol 22:373–376PubMedCrossRef

Hung JH, Ng HT, Pan YP, Yang MJ, Shu LP (1997) Color Doppler ultrasound, pregnancy-induced hypertension and small-for-gestational-age fetuses. Int J Gynaecol Obstet 56:3–11PubMedCrossRef

Hutcheon JA, Zhang X, Cnattingius S, Kramer MS, Platt RW (2008) Customised birthweight percentiles: does adjusting for maternal characteristics matter? Br J Obstet Gynaecol 115:1397–1404CrossRef

Hutcheon JA, Zhang X, Platt RW, Cnattingius S, Kramer MS (2011) The case against customised birthweight standards. Paediatr Perinat Epidemiol 25:11–16PubMedCrossRef

Iliodromiti S, Mackay DF, Smith GC, Pell JP, Sattar N, Lawlor DA, Nelson SM (2017) Customised and noncustomised birth weight centiles and prediction of stillbirth and infant mortality and morbidity: A cohort study of 979,912 term singleton pregnancies in Scotland. PLoS Med 14:e1002228PubMedPubMedCentralCrossRef

Irion O, Masse J, Forest JC, Moutquin JM (1998) Prediction of pre-eclampsia, low birthweight for gestation and prematurity by uterine artery blood flow velocity waveforms analysis in low risk nulliparous women. Br J Obstet Gynaecol 105:422–429PubMedCrossRef

Kehl S, Dötsch J, Hecher K, Schlembach D, Schmitz D, Stepan H, Gembruch U (2017) Intrauterine growth restriction. Guideline of the German Society of Gynecology and Obstetrics (S2k-Level, AWMF Registry No. 015/080, October 2016). Geburtshilfe Frauenheilkd 77:1157–1173PubMedPubMedCentralCrossRef

Kurmanavicius J, Florio I, Wisser J, Hebisch G, Zimmermann R, Muller R, Huch R, Huch A (1997) Reference resistance indices of the umbilical, fetal middle cerebral and uterine arteries at 24–42 weeks of gestation. Ultrasound Obstet Gynecol 10:112–120PubMedCrossRef

Lai J, Syngelaki A, Nicolaides KH, von Dadelszen P, Magee LA (2021) Impact of new definitions of preeclampsia at term on identification of adverse maternal and perinatal outcomes. Am J Obstet Gynecol 224:518.e1–518.11PubMedCrossRef

Lees CC, Romero R, Stampalija T, Dall’Asta A, DeVore GA, Prefumo F, Frusca T, Visser GHA, Hobbins JC, Baschat AA, Bilardo CM, Galan HL, Campbell S, Maulik D, Figueras F, Lee W, Unterscheider J, Valensise H, Da Silva Costa F, Salomon LJ, Poon LC, Ferrazzi E, Mari G, Rizzo G, Kingdom JC, Kiserud T, Hecher K (2022) Clinical opinion: the diagnosis and management of suspected fetal growth restriction: an evidence-based approach. Am J Obstet Gynecol 226:366–378PubMedPubMedCentralCrossRef

Lefebvre J, Demers S, Bujold E, Nicolaides KH, Girard M, Brassard N, Audibert F (2012) Comparison of two different sites of measurement for transabdominal uterine artery Doppler velocimetry at 11–13 weeks. Ultrasound Obstet Gynecol 40:288–292PubMedCrossRef

Leible S, Muñoz H, Walton R, Sabaj V, Cumsille F, Sepulveda W (1998) Uterine artery blood flow velocity waveforms in pregnant women with müllerian duct anomaly: a biologic model for uteroplacental insufficiency. Am J Obstet Gynecol 178:1048–1053PubMedCrossRef

Levine RJ, Maynard SE, Qian C, Lim K-H, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA (2004) Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350:672–683PubMedCrossRef

Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, Karumanchi SA, CPEP Study Group (2006) Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 355:992–1005PubMedCrossRef

Levine RJ, Lindheimer MD (2009) First-trimester prediction of early preeclampsia: a possibility at last! Hypertension 53:747–748PubMedCrossRef

Litwinska M, Wright D, Efeturk T, Ceccacci I, Nicolaides KH (2017) Proposed clinical management of pregnancies after combined screening for pre-eclampsia at 19–24 weeks’ gestation. Ultrasound Obstet Gynecol 50:367–372PubMedCrossRef

Litwinska M, Syngelaki A, Wright A, Wright D, Nicolaides KH (2018) Management of pregnancies after combined screening for pre-eclampsia at 19–24 weeks’ gestation. Ultrasound Obstet Gynecol 52:365–372PubMedCrossRef

Magee LA, Nicolaides KH, von Dadelszen P (2022a) Preeclampsia. N Engl J Med 386:1817–1832

Magee LA, Brown MA, Hall DR, Gupte S, Hennessy A, Karumanchi SA, Kenny LC, McCarthy F, Myers J, Poon LC, Rana S, Saito S, Staff AC, Tsigas E, von Dadelszen P (2022b) The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens 27:148–169PubMedCrossRef

Magee LA, Wright D, Syngelaki A, von Dadelszen P, Akolekar R, Wright A, Nicolaides KH (2023) Preeclampsia prevention by timed birth at term. Hypertension 80:969–978PubMedCrossRef

Maynard SE, Min J-Y, Merchan J, Lim K-H, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111:649–658PubMedPubMedCentralCrossRef

McCowan LM, Figueras F, Anderson NH (2018) Evidence-based national guidelines for the management of suspected fetal growth restriction: comparison, consensus, and controversy. Am J Obstet Gynecol 218:S855–S868PubMedCrossRef

McDonald SD, Malinowski A, Zhou Q, Yusuf S, Devereaux PJ (2008) Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and metaanalyses. Am Heart J 156:918–930PubMedCrossRef

Melamed N, Baschat A, Yinon Y, Athanasiadis A, Mecacci F, Figueras F, Berghella V, Nazareth A, Tahlak M, McIntyre HD, Da Silva Costa F, Kihara AB, Hadar E, McAuliffe F, Hanson M, Ma RC, Gooden R, Sheiner E, Kapur A, Divakar H, Ayres-de-Campos D, Hiersch L, Poon LC, Kingdom J, Romero R, Hod M (2021) FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction. Int J Gynaecol Obstet 152(Suppl 1):3–57PubMedPubMedCentralCrossRef

Milne F, Redman C, Walker J, Baker P, Black R, Blincowe J, Cooper C, Fletcher G, Jokinen M, Moran PA, Nelson-Piercy C, Robson S, Shennan A, Tuffnell A, Waugh J (2009) Assessing the onset of pre-eclampsia in the hospital day unit: summary of the pre-eclampsia guideline (PRECOG II). BMJ 339:b3129PubMedCrossRef

Noguchi J, Hata K, Tanaka H, Hata T (2009) Placental vascular sonobiopsy using three-dimensional power Doppler ultrasound in normal and growth restricted fetuses. Placenta 30:391–397PubMedCrossRef

North RA, McCowan LM, Dekker GA, Poston L, Chan EH, Stewart AW, Black MA, Taylor RS, Walker JJ, Baker PN, Kenny LC (2011) Clinical risk prediction for pre-eclampsia in nulliparous women: development of model in international prospective cohort. BMJ 342:d1875PubMedPubMedCentralCrossRef

Ochi H, Suginami H, Matsubara K, Taniguchi H, Yano J, Matsuura S (1995) Microbead embolization of uterine spiral arteries and changes in uterine arterial flow velocity waveforms in the pregnant ewe. Ultrasound Obstet Gynecol 6:272–276PubMedCrossRef

Ochi H, Matsubara K, Kusanagi Y, Taniguchi H, Ito M (1998) Significance of a diastolic notch in the uterine artery flow velocity waveform induced by uterine embolisation in the pregnant ewe. Br J Obstet Gynaecol 105:1118–1121PubMedCrossRef

Oliveira N, Magder LS, Blitzer MG, Baschat AA (2014a) First-trimester prediction of pre-eclampsia: external validity of algorithms in a prospectively enrolled cohort. Ultrasound Obstet Gynecol 44:279–285PubMedCrossRef

Oliveira N, Doyle LE, Atlas RO, Jenkins CB, Blitzer MG, Baschat AA (2014b) External validity of first-trimester algorithms in the prediction of pre-eclampsia disease severity. Ultrasound Obstet Gynecol 44:286–292PubMedCrossRef

Onwudiwe N, Yu CK, Poon LC, Spiliopoulos I, Nicolaides KH (2008) Prediction of pre-eclampsia by a combination of maternal history, uterine artery Doppler and mean arterial pressure. Ultrasound Obstet Gynecol 32:877–883PubMedCrossRef

Panaitescu A, Ciobanu A, Syngelaki A, Wright A, Wright D, Nicolaides KH (2018) Screening for pre-eclampsia at 35–37 weeks’ gestation. Ultrasound Obstet Gynecol 52:501–506PubMedCrossRef

Papageorghiou AT (2008) Predicting and preventing pre-eclampsia – where to next? Ultrasound Obstet Gynecol 31:367–370PubMedCrossRef

Papageorghiou AT, Yu CK, Bindra R, Pandis G, Nicolaides KH (2001) Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation. Ultrasound Obstet Gynecol 18:441–449PubMedCrossRef

Papastefanou I, Thanopoulou V, Dimopoulou S, Syngelaki A, Akolekar R, Nicolaides KH (2022) Competing-risks model for prediction of small-for-gestational-age neonate at 36 weeks’ gestation. Ultrasound Obstet Gynecol 60:61–69CrossRef

Pedrosa AC, Matias A (2011) Screening for pre-eclampsia: a systematic review of tests combining uterine artery Doppler with other markers. J Perinat Med 39:619–635PubMedCrossRef

Poon LC, Volpe N, Muto B, Syngelaki A, Nicolaides KH (2012) Birthweith with gestation and maternal characteristics in live births and stillbirths. Fetal Diagn Ther 32:156–165PubMedCrossRef

Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, McAuliffe F, da Silva Costa F, von Dadelszen P, McIntyre HD, Kihara AB, Di Renzo GC, Romero R, D’Alton M, Berghella V, Nicolaides KH, Hod M (2019) The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. Int J Gynaecol Obstet 145 Suppl 1:1–33CrossRef

Poon LC, Galindo A, Surbek D, Chantraine F, Stepan H, Hyett J, Tan KH, Verlohren S (2020) From first-trimester screening to risk stratification of evolving pre-eclampsia in second and third trimesters of pregnancy: comprehensive approach. Ultrasound Obstet Gynecol 55:5–12PubMedCrossRef

Poon LC, Magee LA, Verlohren S, Shennan A, von Dadelszen P, Sheiner E, Hadar E, Visser G, Da Silva Costa F, Kapur A, McAuliffe F, Nazareth A, Tahlak M, Kihara AB, Divakar H, McIntyre HD, Berghella V, Yang H, Romero R, Nicolaides KH, Melamed N, Hod M (2021) A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre-eclampsia: compiled by the Pregnancy and Non-Communicable Diseases Committee of FIGO (the International Federation of Gynecology and Obstetrics). Int J Gynaecol Obstet 154(Suppl 1):3–31PubMedPubMedCentralCrossRef

Ramlakhan KP, Johnson MR, Roos-Hesselink JW (2020) Pregnancy and cardiovascular disease. Nat Rev Cardiol 17:718-731PubMedCrossRef

Rana S, Powe CE, Salahuddin S, Verlohren S, Perschel FH, Levine RJ, Lim KH, Wenger JB, Thadhani R, Karumanchi SA (2012) Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation 125:911–919PubMedPubMedCentralCrossRef

Rana S, Schnettler WT, Powe C, Wenger J, Salahuddin S, Cerdeira AS, Verlohren S, Perschel FH, Arany Z, Lim KH, Thadhani R, Karumanchi SA (2013) Clinical characterization and outcomes of preeclampsia with normal angiogenic profile. Hypertens Pregnancy 32:189–201PubMedPubMedCentralCrossRef

Rolnik DL, Wright D, Poon LC, O’Gorman N, Syngelaki A, de Paco Matallana C, Akolekar R, Cicero S, Janga D, Singh M, Molina FS, Persico N, Jani JC, Plasencia W, Papaioannou G, Tenenbaum-Gavish K, Meiri H, Gizurarson S, Maclagan K, Nicolaides KH (2017) Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med 377:613–622PubMedCrossRef

Romero R, Erez O, Hüttemann M, Maymon E, Panaitescu B, Conde-Agudelo A, Pacora P, Yoon BH, Grossman LI (2017) Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity. Am J Obstet Gynecol 217:282–302PubMedPubMedCentralCrossRef

Royal College of Obstetricians and Gynaecologists (2014) The investigation and management of the small–for–gestational–age fetus. Green-top guideline No. 31. RCOG. https://www.rcog.org.uk/media/t3lmjhnl/gtg_31.pdf

Savirón-Cornudella R, Esteban LM, Aznar-Gimeno R, Dieste-Pérez P, Pérez-López FR, Campillos JM, Castán-Larraz B, Sanz G, Tajada-Duaso M (2021) Prediction of late-onset small for gestational age and fetal growth restriction by fetal biometry at 35 weeks and Impact of ultrasound-delivery interval: comparison of six fetal growth standards. J Clin Med 10:2984PubMedPubMedCentralCrossRef

Savvidou MD, Karanastasi E, Skentou C, Geerts L, Nicolaides KH (2001) Twin chorionicity and pre-eclampsia. Ultrasound Obstet Gynecol 18:228–231PubMedCrossRef

Schlembach D, Hund M, Wolf C, Vatish M (2019) Diagnostic utility of angiogenic biomarkers in pregnant women with suspected preeclampsia: a health economics review. Pregnancy Hypertens 17:28–35PubMedCrossRef

Scholten RR, Hopman MT, Sweep FC, Van de Vlugt MJ, Van Dijk AP, Oyen WJ, Lotgering FK, Spaanderman ME (2013) Co-occurrence of cardiovascular and prothrombotic risk factors in women with a history of pre-eclampsia. Obstet Gynecol 121:97–105PubMedCrossRef

Sibai B, Dekker G, Kupferminc M (2005) Pre-eclampsia. Lancet 365:785–799PubMedCrossRef

Souka AP, Papastefanou I, Pilalis A, Michalitsi V, Panagopoulos P, Kassanos D (2013) Performance of the ultrasound examination in the early and late third trimester for the prediction of birth weight deviations. Prenat Diagn 33:915–920PubMedCrossRef

Sovio U, Gaccioli F, Cook E, Hund M, Charnock-Jones DS, Smith GC (2017) Prediction of preeclampsia using the soluble fms-Like tyrosine kinase 1 to placental growth factor ratio: a prospective cohort study of unselected nulliparous women. Hypertension 69:731–738PubMedCrossRef

Spencer K, Yu CK, Savvidou M, Papageorghiou AT, Nicolaides KH (2006) Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein – A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks’ gestation. Ultrasound Obstet Gynecol 27:658–663PubMedCrossRef

Spencer K, Cowans NJ, Chefetz I, Tal J, Meiri H (2007) First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia. Ultrasound Obstet Gynecol 29:128–134PubMedCrossRef

Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R (2010) Pre-eclampsia. Lancet 376:631–644PubMedCrossRef

Stepan H, Unversucht A, Wessel N, Faber R (2007) Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion. Hypertension 49:818–824PubMedCrossRef

Subtil D, Goeusse P, Houfflin-Debarge V, Puech F, Lequien P, Breart G, Uzan S, Quandalle F, Delcourt YM, Malek YM (2003) Randomised comparison of uterine artery Doppler and aspirin (100 mg) with placebo in nulliparous women: the Essai Regional Aspirine Mere-Enfant study (Part 2). BJOG 110:485–491PubMedCrossRef

Suresh S, Patel E, Mueller A, Morgan J, Lewandowski WL, Verlohren S, von Dadelszen P, Magee LA, Rana S (2023) The additive role of angiogenic markers for women with confirmed preeclampsia. Am J Obstet Gynecol 228:573.e1–573.11PubMedCrossRef

Tan MY, Wright D, Koutoulas L, Akolekar R, Nicolaides KH (2017) Comparison of screening for pre-eclampsia at 31–34 weeks’ gestation by sFlt-1/PlGF ratio and a method combining maternal factors with sFlt-1 and PlGF. Ultrasound Obstet Gynecol 49:201–208PubMedCrossRef

Tan MY, Syngelaki A, Poon LC, Rolnik DL, O’Gorman N, Delgado JL, Akolekar R, Konstantinidou L, Tsavdaridou M, Galeva S, Ajdacka U, Molina FS, Persico N, Jani JC, Plasencia W, Greco E, Papaioannou G, Wright A, Wright D, Nicolaides KH (2018) Screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks’ gestation. Ultrasound Obstet Gynecol 52:186–195PubMedCrossRef

Täufer Cederlöf E, Lundgren M, Lindahl B, Christersson C (2022) Pregnancy complications and risk of cardiovascular disease later in life: a nationwide cohort study. J Am Heart Assoc 11:e023079PubMedPubMedCentralCrossRef

Thadhani R, Lemoine E, Rana S, Costantine MM, Calsavara VF, Boggess K, Wylie BJ, Moore Simas TA, Louis JM, Espinoza J, Gaw SL, Murtha A, Wiegand S, Gollin Y, Singh D, Silver RM, Durie DE, Panda B, Norwitz ER, Burd I, Plunkett B, Scott RK, Gaden A, Bautista M, Chang Y, Diniz MA, Karumanchi SA, Kilpatrick S (2022) Circulating angiogenic factor levels in hypertensive disorders of pregnancy. NEJM Evid 1:EVIDoa2200161PubMedCrossRef

Thangaratinam S, Coomarasamy A, Sharp S, O’Mahony F, O’Brien S, Ismail KM, Khan KS (2008) Tests for predicting complications of pre-eclampsia: a protocol for systematic reviews. BMC Pregnancy Childbirth 8:38PubMedPubMedCentralCrossRef

Trogstad L, Magnus P, Stoltenberg C (2011) Pre-eclampsia: risk factors and causal models. Best Pract Res Clin Obstet Gynaecol 25:329–342PubMedCrossRef

Trudinger BJ, Stevens D, Connelly A, Hales JR, Alexander G, Bradley L, Fawcett A, Thompson RS (1987) Umbilical artery flow velocity waveforms and placental resistance: the effects of embolization of the umbilical circulation. Am J Obstet Gynecol 157:1443–1448PubMedCrossRef

Tsiakkas A, Saiid Y, Wright A, Wright D, Nicolaides KH (2016) Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 30–34 weeks’ gestation. Am J Obstet Gynecol 215:87.e1–87.17PubMedCrossRef

Valensise H, Novelli GP, Vasapollo B, Borzi M, Arduini D, Galante A, Romanini C (2000) Maternal cardiac systolic and diastolic function: relationship with uteroplacental resistances. A Doppler and echocardiographic longitudinal study. Ultrasound Obstet Gynecol 15:487–497PubMedCrossRef

Valensise H, Vasapollo B, Gagliardi G, Novelli GP (2008) Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertension 52:873–880PubMedCrossRef

Vasak B, Koenen SV, Koster MP, Hukkelhoven CW, Franx A, Hanson MA, Visser GH (2015) Human fetal growth is constrained below optimal for perinatal survival. Ultrasound Obstet Gynecol 45:162–167CrossRef

Vergani P, Roncaglia N, Andreotti C, Arreghini A, Teruzzi M, Pezzullo JC, Ghidini A (2002) Prognostic value of uterine artery Doppler velocimetry in growthrestricted fetuses delivered near term. Am J Obstet Gynecol 187:932–936PubMedCrossRef

Verlohren S, Galindo A, Schlembach D, Zeisler H, Herraiz I, Moertl MG, Pape J, Dudenhausen JW, Denk B, Stepan H (2010) An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia. Am J Obstet Gynecol 202:161.e1–161.11PubMedCrossRef

Verlohren S, Herraiz I, Lapaire O, Schlembach D, Moertl M, Zeisler H, Calda P, Holzgreve W, Galindo A, Engels T, Denk B, Stepan H (2012) The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol 206:58.e1–58.e8PubMedCrossRef

Verlohren S, Herraiz I, Lapaire O, Schlembach D, Zeisler H, Calda P, Sabria J, Markfeld-Erol F, Galindo A, Schoofs K, Denk B, Stepan H (2014) New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia. Hypertension 63:346–352PubMedCrossRef

Visintin C, Mugglestone MA, Almerie MQ, Nherera LM, James D, Walkinshaw S (2010) Management of hypertensive disorders during pregnancy: summary of NICE guidance. BMJ 341:c2207PubMedCrossRef

Waterstone M, Bewley S, Wolfe C (2001) Incidence and predictors of severe obstetric morbidity: case-control study. BMJ 322:1089–1093 (discussion 1093–1094))PubMedPubMedCentralCrossRef

Wright D, Tan MY, O’Gorman N, Poon LC, Syngelaki A, Wright A, Nicolaides KH (2019) Predictive performance of the competing risk model in screening for preeclampsia. Am J Obstet Gynecol 220:199.e1–199.13PubMedCrossRef

Wright D, Wright A, Smith E, Nicolaides KH (2020) Impact of biometric measurement error on identification of small- and large-for-gestational-age fetuses. Ultrasound Obstet Gynecol 55:170–176PubMedPubMedCentralCrossRef

Wu P, Kwok CS, Haththotuwa R, Kotronias RA, Babu A, Fryer AA, Myint PK, Chew-Graham CA, Mamas MA (2016) Pre-eclampsia is associated with a twofold increase in diabetes: a systematic review and meta-analysis. Diabetologia 59:2518–2526.PubMedPubMedCentralCrossRef

Wu P, Haththotuwa R, Kwok CS, Babu A, Kotronias RA, Rushton C, Zaman A, Fryer AA, Kadam U, Chew-Graham CA, Mamas MA. (2017) Preeclampsia and future cardiovascular health: A systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes 10:e003497PubMedCrossRef

Yu CK, Papageorghiou AT, Boli A, Cacho AM, Nicolaides KH (2002) Screening for pre-eclampsia and fetal growth restriction in twin pregnancies at 23 weeks of gestation by transvaginal uterine artery Doppler. Ultrasound Obstet Gynecol 20:535–540PubMedCrossRef

Yu CK, Papageorghiou AT, Parra M, Palma Dias R, Nicolaides Fetal Medicine Foundation Second Trimester Screening Group (2003) Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks’ gestation. Ultrasound Obstet Gynecol 22:233–239PubMedCrossRef

Yu J, Shixia CZ, Wu Y, Duan T (2011) Inhibin A, activin A, placental growth factor and uterine artery Doppler pulsatility index in the prediction of preeclampsia. Ultrasound Obstet Gynecol 37:528–533PubMedCrossRef

Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennström M, Olovsson M, Brennecke SP, Stepan H, Allegranza D, Dilba P, Schoedl M, Hund M, Verlohren S (2016a) Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia. N Engl J Med 374:13–22PubMedCrossRef

Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennstrom M, Olovsson M, Brennecke SP, Stepan H, Allegranza D, Dinkel C, Schoedl M, Dilba P, Hund M, Verlohren S (2016b) Soluble fms-like tyrosine kinase-1-to-placental growth factor ratio and time to delivery in women With suspected preeclampsia. Obstet Gynecol 128:261–269PubMedCrossRef

Zeisler H, Llurba E, Chantraine FJ, Vatish M, Staff AC, Sennstrom M, Olovsson M, Brennecke SP, Stepan H, Allegranza D, Schoedl M, Grill S, Hund M, Verlohren S (2019) Soluble fms-like tyrosine kinase-1 to placental growth factor ratio: ruling out pre-eclampsia for up to 4 weeks and value of retesting. Ultrasound Obstet Gynecol 53:367–375PubMedPubMedCentralCrossRef

Titel: Prädiktiver Ultraschall, Screening und Vorhersage für Präeklampsie und fetale Wachstumsrestriktion im II. und III. Trimester
verfasst von: Prof. Dr. med. Stefan Verlohren
Priv.-Doz. Dr. med. Arne Willruth
Prof. Dr. med. Ulrich Gembruch
Verlag: Springer Berlin Heidelberg
Buch: Ultraschalldiagnostik in Geburtshilfe und Gynäkologie
Print ISBN: 978-3-662-67372-0

Electronic ISBN: 978-3-662-67373-7

Copyright-Jahr: 2025
DOI: https://doi.org/10.1007/978-3-662-67373-7_19

Springerpflege

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten